Ethan Martin, MBA
About Ethan Martin, MBA
Ethan Martin, MBA, is an Oncology Territory Manager at Novocure with over 20 years of experience in pharmaceutical and medical device sales.
Company
Ethan Martin is currently employed at Novocure as an Oncology Territory Manager. Novocure is known for its focus on innovative cancer treatment solutions, which aligns with Ethan's extensive background in pharmaceutical and medical device sales. He transitioned to this managerial role in 2019, marking a significant milestone in his career.
Title
Ethan Martin holds the position of Oncology Territory Manager at Novocure. In this capacity, he is responsible for overseeing the oncology sales territory, leveraging his extensive experience to drive sales strategies and manage customer relationships in the oncology sector.
Education and Expertise
Ethan Martin holds a Master of Business Administration (MBA) from the University of Pikeville, completed in 2021. He also has a Bachelor of Arts in Communication from Morehead State University, earned in 2002. His formal education, combined with over 20 years of hands-on experience in pharmaceutical and medical device sales, provides a strong foundation for his current role in oncology territory management.
Background
Ethan Martin has accumulated over 20 years of experience in the pharmaceutical and medical device sales industry. Starting his career in 2003 at Wyeth as a Sales Representative, he subsequently worked at Boehringer Ingelheim, Ventana Medical Systems, and Pfizer in various sales roles. His tenure at Pfizer included both institutional and territory sales positions, highlighting his versatile expertise in this field.
Career Path
Ethan Martin's career path includes significant roles at several major pharmaceutical companies. After starting at Wyeth, he worked at Boehringer Ingelheim for three years before moving to Ventana Medical Systems, and then Pfizer, where he held both Territory Sales Representative and Institutional Sales positions. He later served as a Sales Consultant for DePuy Synthes Companies before transitioning to his current role at Novocure.